# EDGAR Filing Document

**Accession Number:** 0001859902
**File Stem:** 0001104659-23-007261
**Filing Date:** 2023-1
**Character Count:** 2626
**Document Hash:** a08888ba845ae27dfa819d800b7de9e8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-007261.hdr.sgml**: 20230127

**ACCESSION NUMBER**: 0001104659-23-007261

**CONFORMED SUBMISSION TYPE**: 15-12G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230127

**DATE AS OF CHANGE**: 20230127

**EFFECTIVENESS DATE**: 20230127

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Valens Company, Inc.
- **CENTRAL INDEX KEY:** 0001859902
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1130

**FILING VALUES:**
- **FORM TYPE:** 15-12G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41080
- **FILM NUMBER:** 23559715

**BUSINESS ADDRESS:**
- **STREET 1:** 230 CARION ROAD
- **CITY:** KELOWNA
- **STATE:** Z4
- **ZIP:** V4V 2K5
- **BUSINESS PHONE:** 778-755-0052

**MAIL ADDRESS:**
- **STREET 1:** 230 CARION ROAD
- **CITY:** KELOWNA
- **STATE:** Z4
- **ZIP:** V4V 2K5

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM 15** 

**CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION** 

**UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934** 

**OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)** 

**OF THE SECURITIES EXCHANGE ACT OF 1934.**

**Commission File No.: 001-41080**

**THE VALENS COMPANY INC.**

**(Exact name of Issuer as specified in its charter)** 

**230 Carion Road**

**Kelowna, BC, Canada V4V 2K5**

**(778) 755-0052** 

**(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)** 

**Common Shares, no par value** 

**(Title of each class of securities covered by this Form)** 

**None** 

**(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)** 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

---

| | |
|:---|:---|
| Rule 12g-4(a)(1) | x |
| Rule 12g-4(a)(2) | ¨ |
| Rule 12h-3(b)(1)(i) | x |
| Rule 12h-3(b)(1)(ii) | ¨ |
| Rule 15d-6 | ¨ |
| Rule 15d-22(b) | ¨ |

---

Approximate number of holders of record as of the certification or notice date: One (1)

Pursuant to the requirements of the Securities Exchange Act of 1934, The Valens Company Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

---

| | | |
|:---|:---|:---|
| Date: January 27, 2023 | By: | /s/ Zachary George |
|  | Name: | Zachary George |
|  | Title: | Chief Executive Officer |

---